Matches in Nanopublications for { ?s ?p "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759812.RAjizQNP0YLaB8aep7HWmPwyCKLuJyu6gzh-ySID4mXB8130_provenance.
- NP763846.RAoP8nfAO2NzGPMhCNnGbO8v8UlSMUD-PkAbpUE5D4j9E130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP763846.RAoP8nfAO2NzGPMhCNnGbO8v8UlSMUD-PkAbpUE5D4j9E130_provenance.
- NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448682.RAW2SEKUzFwMVoMmhunuPDWlNQfSXw28seJKTzPfIGTeY130_provenance.
- NP735291.RAipSTC-6eoKMcFfBDvB6dKM4J0MbeW9WvyhcfJ0duhNU130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735291.RAipSTC-6eoKMcFfBDvB6dKM4J0MbeW9WvyhcfJ0duhNU130_provenance.
- NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711051.RAYDKm3AQ2wPSMaN-xATPUx42LD2STU2IckeLTVJenURY130_provenance.
- NP816528.RA6sRwkMFFH2XMzSwP9htxFS-nZHlb11aLCgJjr9gCd8o130_assertion description "[Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816528.RA6sRwkMFFH2XMzSwP9htxFS-nZHlb11aLCgJjr9gCd8o130_provenance.